Several deubiquitination enzymes, such as CSN5, USP1, USP19, and STAMBPL1, prevent the ubiquitin degradation process of survivin and stabilize its expression, leading to tumor progression and therapeutic resistance 48-50. The gene discussed is BIRC5; the disease is neoplasm.